Recent clinical studies indicate that the Apo B/A1 ratio, which may reflect the cholesterol balance between atherogenic and antiatherogenic lipoprotein particles, is a strong predictor of risk for atherosclerotic cardiovascular disease (ASCVD) [3, 4]. Here, APOB is linked to atherosclerosis.